Cargando…
An in silico drug treatment model to assess the robustness of regional age-based dosing regimens for artemisinin-based combination therapies
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472405/ http://dx.doi.org/10.1186/1475-2875-11-S1-P91 |
| _version_ | 1782246602659856384 |
|---|---|
| author | Staehli Hodel, Eva Maria Kay, Katherine Hayes, Daniel Terlouw, Anja Hastings, Ian |
| author_facet | Staehli Hodel, Eva Maria Kay, Katherine Hayes, Daniel Terlouw, Anja Hastings, Ian |
| author_sort | Staehli Hodel, Eva Maria |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3472405 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-34724052012-10-23 An in silico drug treatment model to assess the robustness of regional age-based dosing regimens for artemisinin-based combination therapies Staehli Hodel, Eva Maria Kay, Katherine Hayes, Daniel Terlouw, Anja Hastings, Ian Malar J Poster Presentation BioMed Central 2012-10-15 /pmc/articles/PMC3472405/ http://dx.doi.org/10.1186/1475-2875-11-S1-P91 Text en Copyright ©2012 Staehli Hodel et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Poster Presentation Staehli Hodel, Eva Maria Kay, Katherine Hayes, Daniel Terlouw, Anja Hastings, Ian An in silico drug treatment model to assess the robustness of regional age-based dosing regimens for artemisinin-based combination therapies |
| title | An in silico drug treatment model to assess the robustness of regional age-based dosing regimens for artemisinin-based combination therapies |
| title_full | An in silico drug treatment model to assess the robustness of regional age-based dosing regimens for artemisinin-based combination therapies |
| title_fullStr | An in silico drug treatment model to assess the robustness of regional age-based dosing regimens for artemisinin-based combination therapies |
| title_full_unstemmed | An in silico drug treatment model to assess the robustness of regional age-based dosing regimens for artemisinin-based combination therapies |
| title_short | An in silico drug treatment model to assess the robustness of regional age-based dosing regimens for artemisinin-based combination therapies |
| title_sort | in silico drug treatment model to assess the robustness of regional age-based dosing regimens for artemisinin-based combination therapies |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472405/ http://dx.doi.org/10.1186/1475-2875-11-S1-P91 |
| work_keys_str_mv | AT staehlihodelevamaria aninsilicodrugtreatmentmodeltoassesstherobustnessofregionalagebaseddosingregimensforartemisininbasedcombinationtherapies AT kaykatherine aninsilicodrugtreatmentmodeltoassesstherobustnessofregionalagebaseddosingregimensforartemisininbasedcombinationtherapies AT hayesdaniel aninsilicodrugtreatmentmodeltoassesstherobustnessofregionalagebaseddosingregimensforartemisininbasedcombinationtherapies AT terlouwanja aninsilicodrugtreatmentmodeltoassesstherobustnessofregionalagebaseddosingregimensforartemisininbasedcombinationtherapies AT hastingsian aninsilicodrugtreatmentmodeltoassesstherobustnessofregionalagebaseddosingregimensforartemisininbasedcombinationtherapies AT staehlihodelevamaria insilicodrugtreatmentmodeltoassesstherobustnessofregionalagebaseddosingregimensforartemisininbasedcombinationtherapies AT kaykatherine insilicodrugtreatmentmodeltoassesstherobustnessofregionalagebaseddosingregimensforartemisininbasedcombinationtherapies AT hayesdaniel insilicodrugtreatmentmodeltoassesstherobustnessofregionalagebaseddosingregimensforartemisininbasedcombinationtherapies AT terlouwanja insilicodrugtreatmentmodeltoassesstherobustnessofregionalagebaseddosingregimensforartemisininbasedcombinationtherapies AT hastingsian insilicodrugtreatmentmodeltoassesstherobustnessofregionalagebaseddosingregimensforartemisininbasedcombinationtherapies |